Page last updated: 2024-10-31

midazolam and Hyperammonemia

midazolam has been researched along with Hyperammonemia in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Hyperammonemia: Elevated level of AMMONIA in the blood. It is a sign of defective CATABOLISM of AMINO ACIDS or ammonia to UREA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belze, O1
Remérand, F1
Pujol, A1
Fusciardi, J1
Velioğlu, SK1
Gazioğlu, S1

Other Studies

2 other studies available for midazolam and Hyperammonemia

ArticleYear
Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid.
    Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:8

    Topics: Adult; Anesthesia, General; Anticonvulsants; Brain Diseases; Craniocerebral Trauma; Electroencephalo

2013
Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Acta neurologica Scandinavica, 2007, Volume: 116, Issue:2

    Topics: Adult; Ammonia; Anticonvulsants; Brain; Electroencephalography; Hepatic Encephalopathy; Humans; Hype

2007